These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

464 related articles for article (PubMed ID: 25259747)

  • 1. Targeting nocturnal hypertension in type 2 diabetes mellitus.
    Rossen NB; Knudsen ST; Fleischer J; Hvas AM; Ebbehøj E; Poulsen PL; Hansen KW
    Hypertension; 2014 Nov; 64(5):1080-7. PubMed ID: 25259747
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chronotherapy with valsartan/hydrochlorothiazide combination in essential hypertension: improved sleep-time blood pressure control with bedtime dosing.
    Hermida RC; Ayala DE; Mojón A; Fontao MJ; Fernández JR
    Chronobiol Int; 2011 Aug; 28(7):601-10. PubMed ID: 21823969
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of time-of-day of hypertension treatment on ambulatory blood pressure and clinical characteristics of patients with type 2 diabetes.
    Moyá A; Crespo JJ; Ayala DE; Ríos MT; Pousa L; Callejas PA; Salgado JL; Mojón A; Fernández JR; Hermida RC;
    Chronobiol Int; 2013 Mar; 30(1-2):116-31. PubMed ID: 23181613
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The bedtime administration ameliorates blood pressure variability and reduces urinary albumin excretion in amlodipine-olmesartan combination therapy.
    Hoshino A; Nakamura T; Matsubara H
    Clin Exp Hypertens; 2010; 32(7):416-22. PubMed ID: 20828223
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment-time regimen of hypertension medications significantly affects ambulatory blood pressure and clinical characteristics of patients with resistant hypertension.
    Hermida RC; Ríos MT; Crespo JJ; Moyá A; Domínguez-Sardiña M; Otero A; Sánchez JJ; Mojón A; Fernández JR; Ayala DE;
    Chronobiol Int; 2013 Mar; 30(1-2):192-206. PubMed ID: 23098160
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 24-hour and nighttime blood pressures in type 2 diabetic hypertensive patients following morning or evening administration of olmesartan.
    Tofé Povedano S; García De La Villa B
    J Clin Hypertens (Greenwich); 2009 Aug; 11(8):426-31. PubMed ID: 19695030
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Perspectives on the chronotherapy of hypertension based on the results of the MAPEC study.
    Portaluppi F; Smolensky MH
    Chronobiol Int; 2010 Sep; 27(8):1652-67. PubMed ID: 20854140
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bedtime administration of long-acting antihypertensive drugs restores normal nocturnal blood pressure fall in nondippers with essential hypertension.
    Takeda A; Toda T; Fujii T; Matsui N
    Clin Exp Nephrol; 2009 Oct; 13(5):467-472. PubMed ID: 19449087
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chronotherapy with valsartan/amlodipine fixed combination: improved blood pressure control of essential hypertension with bedtime dosing.
    Hermida RC; Ayala DE; Fontao MJ; Mojón A; Fernández JR
    Chronobiol Int; 2010 Jul; 27(6):1287-303. PubMed ID: 20653455
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of combination olmesartan medoxomil plus azelnidipine versus monotherapy with either agent on 24-hour ambulatory blood pressure and pulse rate in Japanese patients with essential hypertension: additional results from the REZALT study.
    Shimada K; Ogihara T; Saruta T; Kuramoto K;
    Clin Ther; 2010 May; 32(5):861-81. PubMed ID: 20685495
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Administration-time differences in effects of hypertension medications on ambulatory blood pressure regulation.
    Hermida RC; Ayala DE; Fernández JR; Mojón A; Smolensky MH; Fabbian F; Portaluppi F
    Chronobiol Int; 2013 Mar; 30(1-2):280-314. PubMed ID: 23077971
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Administration-time-dependent effects of hypertension treatment on ambulatory blood pressure in patients with chronic kidney disease.
    Crespo JJ; Piñeiro L; Otero A; Castiñeira C; Ríos MT; Regueiro A; Mojón A; Lorenzo S; Ayala DE; Hermida RC;
    Chronobiol Int; 2013 Mar; 30(1-2):159-75. PubMed ID: 23098134
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of circadian time of hypertension treatment on cardiovascular risk: results of the MAPEC study.
    Hermida RC; Ayala DE; Mojón A; Fernández JR
    Chronobiol Int; 2010 Sep; 27(8):1629-51. PubMed ID: 20854139
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nocturnal antihypertensive treatment in patients with type 1 diabetes with autonomic neuropathy and non-dipping: a randomised, placebo-controlled, double-blind cross-over trial.
    Hjortkjær HØ; Jensen T; Kofoed KF; Mogensen UM; Sigvardsen PE; Køber L; Hilsted KL; Corinth H; Theilade S; Hilsted J
    BMJ Open; 2016 Dec; 6(12):e012307. PubMed ID: 27920083
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The bedtime administration of doxazosin controls morning hypertension and albuminuria in patients with type-2 diabetes: evaluation using home-based blood pressure measurements.
    Kamoi K; Ikarashi T
    Clin Exp Hypertens; 2005 May; 27(4):369-76. PubMed ID: 15921073
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of bedtime administration of blood-pressure lowering agents on ambulatory blood pressure monitoring results: A meta-analysis.
    Sun Y; Yu X; Liu J; Zhou N; Chen L; Zhao Y; Li X; Wang J; Cui L
    Cardiol J; 2016; 23(4):473-81. PubMed ID: 27296158
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of effects of angiotensin II receptor blocker on morning home blood pressure and cardiorenal protection between morning administration and evening administration in hypertensive patients: the COMPATIBLE study.
    Mori H; Yamamoto H; Ukai H; Yuasa S; Nakajima K; Mikawa T; Niizuma M; Hirao K; Umemura S;
    Hypertens Res; 2013 Mar; 36(3):202-7. PubMed ID: 23013888
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of an olmesartan medoxomil-based treatment algorithm in patients with hypertension and type 2 diabetes: analysis of diurnal blood pressure control as assessed by 24-hour ambulatory blood pressure monitoring.
    Kereiakes DJ; Neutel J
    Ther Adv Cardiovasc Dis; 2010 Oct; 4(5):285-93. PubMed ID: 20801941
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiovascular risk of essential hypertension: influence of class, number, and treatment-time regimen of hypertension medications.
    Hermida RC; Ayala DE; Mojón A; Fernández JR
    Chronobiol Int; 2013 Mar; 30(1-2):315-27. PubMed ID: 23181712
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of time of day of treatment on ambulatory blood pressure pattern of patients with resistant hypertension.
    Hermida RC; Ayala DE; Calvo C; López JE; Mojón A; Fontao MJ; Soler R; Fernández JR
    Hypertension; 2005 Oct; 46(4):1053-9. PubMed ID: 16087787
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.